Background
Materials and methods
Study population
Clinical and laboratory measurements
Definition of T2DM
REGARDS model
Statistical analysis
Results
Total (N = 1835) | With T2DM (N = 281) | Without T2DM (N = 1554) | P-value | |
---|---|---|---|---|
Sex, men | 837(45.6) | 123(43.8) | 714(45.9) | 0.5 |
Age, (years) | 56.02(7.89) | 56.5(7.6) | 55.9(7.9) | 0.22 |
Body mass index, (kgm2) | 28.27(4.38) | 29.9(4.6) | 28.0(4.3) | < 0.001 |
Waist circumference, (cm) | 95.21(10.33) | 99.6(10.2) | 94.4(10.2) | < 0.001 |
Systolic blood pressure, (mmHg) | 122.76(18.25) | 127.9(17.4) | 121.8(18.3) | < 0.001 |
Diastolic blood pressure, (mmHg) | 77.34(10.47) | 79.7(10.6) | 76.9(10.4) | < 0.001 |
Fasting plasma glucose, (mmol/L) | 5.15(0.54) | 5.62(0.59) | 5.06(0.48) | < 0.001 |
High density lipoprotein cholesterol, (mmol/L) | 1.02(0.27) | 0.98(0.26) | 1.03(0.27) | 0.006 |
Triglycerides, (mmol/L) | 1.72(1.12) | 2.02(1.37) | 1.64(1.05) | < 0.001 |
Family history diabetes, (yes) | 249(13.6) | 56(19.9) | 193(12.4) | 0.001 |
Follow-up duration, (years) | 9.31(1.65) | 9.4(1.71) | 9.3(1.62) | 0.17 |
Responders (N = 1835) | Non-responders (N = 1008) | P-value | |
---|---|---|---|
Sex, men | 837(45.6) | 466(46.2) | 0.75 |
Age, (years) | 56.02(7.89) | 60.17(10.10) | < 0.0001 |
Body mass index, (kgm2) | 28.27(4.38) | 27.93(5.04) | 0.07 |
Waist circumference, (cm) | 95.21(10.33) | 95.38(11.12) | 0.69 |
Systolic blood pressure, (mmHg) | 122.76(18.25) | 127.4(21.55) | < 0.0001 |
Diastolic blood pressure, (mmHg) | 77.34(10.47) | 77.55(11.54) | 0.62 |
Fasting plasma glucose, (mmol/L) | 5.15(0.54) | 92.96(10.07) | 0.71 |
High density lipoprotein cholesterol, (mmol/L) | 1.02(0.27) | 1.03(0.27) | 0.37 |
Triglycerides, (mmol/L) | 1.72(1.12) | 1.61(1.11) | 0.12 |
Family history diabetes, (yes) | 249(13.6) | 125(12.4) | 0.38 |
Follow-up duration, (years) | 9.31(1.65) | 9.32(1.76) | 0.81 |
Probability threshold (%) | ≥ 10 | ≥ 13 | ≥ 20 | ≥ 30 |
---|---|---|---|---|
Population aged ≥ 45 years (N = 1835, DM = 281) | ||||
High-risk population, % | 54.55 | 39.95 | 18.00 | 6.76 |
Incident diabetes*,% | 23.8 | 29.6 | 44.24 | 62.10 |
Sensitivity, % (95% CI) | 84.7 (79.9–88.7) | 77.2 (71.9–82.0) | 52.0 (45.9–57.9) | 27.4 (22.3–33.0) |
Specificity, % (95% CI) | 50.9 (48.4–53.4) | 66.8 (64.4–69.1) | 88.2 (86.4–89.7) | 97.0 (96.0-97.8) |
PPV, % (95% CI) | 23.8 (21.2–26.5) | 29.6 (26.3–33.1) | 44.2 (38.8–49.8) | 62.1 (52.9–70.7) |
NPV, % (95% CI) | 94.8 (93.1–96.2) | 94.2 (92.6–95.5) | 91.0 (89.5–92.4) | 88.1 (86.4–89.6) |
LR+ (95% CI) | 1.73 (1.61–1.85) | 2.33 (2.12–2.56) | 4.39 (3.68–5.23) | 9.1 (6.5–12.7) |
LR- (95% CI) | 0.30 (0.23–0.40) | 0.34 (0.27–0.42) | 0.54 (0.48–0.62) | 0.75 (0.70–0.80) |
Youden Index, % (95% CI) | 35.6 (28.3–42.1) |
44.0 (36.3–51.1)
| 40.2 (32.3–47.6) | 24.4 (18.3–30.8) |
AUC (95% CI) | 0.68 (0.65–0.70) | 0.72 (0.69–0.75) | 0.70 (0.67–0.73) | 0.62 (0.60–0.65) |
Discussion
Prediction model | Population/year | Validation Data | Risk predictors in the final model | Statistical models | C-index/AUC | Calibration |
---|---|---|---|---|---|---|
San Antonio heart study diabetes prediction model [22] | Mexican Americans and Hispanic white/2010 | TLGS cohort / the 6.3-year incidence of T2DM | age, sex, ethnicity, SBP, HDL-C, BMI, FH-DM, FPG | Logistic regression | 0.83 | Acceptable after recalibrated |
The Saint Antonio Diabetes Prediction Model (SA) [23] | Mexican Americans and Hispanic white/2021 | TLGS cohort / The 5-year incidence of T2DM | age, sex, ethnicity, SBP, HDL-C, BMI, FH-DM, FPG | Logistic regression | 0.81 | Acceptable after recalibrated |
Atherosclerosis Risk in Communities Study (ARIC) [24] | American population/2013 | TLGS cohort / The 6-year incidence of T2DM | Age, FH-DM, hypertension, WC, height TG, HDL-C, FPG, race | Cox regression | Men 0.790 Women 0.829 | Acceptable after recalibrated |
Atherosclerosis Risk in Communities Study (ARIC) [23] | American population/2021 | TLGS cohort / The 5-year incidence of T2DM | Age, FH-DM, hypertension, WC, height TG, HDL-C, FPG, race | Logistic regression | 0.83 | Acceptable after recalibrated |
Finnish Diabetes Risk Score (FINDRISC) (4) | Finish population/2019 | TLGS cohort / For undiagnosed T2DM | age, BMI, WC, physical activity, daily consumption of fruits, berries, or vegetables, and the history of antihypertensive drug treatment and history of high blood glucose to predict drug-treated diabetes | Logistic regression | 0.75 | Acceptable after recalibrated |
Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) (4) | Australian population/2019 | TLGS cohort / For undiagnosed T2DM | Non-invasive model: age, sex, ethnicity, FH-DM, history of high blood glucose level, use of antihypertensive medications, smoking, physical inactivity, and WC | Logistic regression | 0.77 | Acceptable calibration |
Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) for undiagnosed diabetes [23] | Australian population/2021 | TLGS cohort / The 5-year incidence of T2DM | Invasive model: age, race, FH-DM, FPG, SBP, WC, height, HDL-C, and TG | Logistic regression | 0.77 | Acceptable after recalibrated |
American Diabetes Association Risk Score (ADA) [4] | American population/2019 | TLGS cohort/ For undiagnosed T2DM | Age, sex, FH-DM, history of hypertension, obesity, and physical activity | Logistic regression | 0.73 | Acceptable after recalibrated |
risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease [25] | Dutch population/2020 | TLGS cohort / For undiagnosed T2DM | Sex stratified analysis: age, BMI, WC, use of antihypertensive medications, current smoking, parent and/or sibling with MI or stroke (age < 65 years), FH-DM | Logistic regression | Men 0.65 Women 0.69 | Not acceptable |
American Diabetes Association screening tool [21] | American population/2020 | national survey of risk factors for non-communicable diseases / For undiagnosed T2DM | Age, sex, FH-DM, history of hypertension, obesity, and physical activity | Logistic regression | 0.737 | Not reported |
The Framingham Offspring Study (FOS) risk score [23] | American population/2021 | TLGS cohort / The 5-year incidence of T2DM | age, gender, FPG, BMI, WC, HDL-C, SBP, FH-DM | Logistic regression | 0.82 | Acceptable after recalibrated |
REasons for Geographic And Racial Differences in Stroke (REGARDS) / Current study | American population | TLGS cohort / The 10-year incidence of T2DM | Age, sex, BMI, SBP, DBP, HDL-C, TG, FPG, and race | Baysian logistic regression | 0.79 | Acceptable calibration |